ClinicalTrials.Veeva

Menu

Determine Safety and Effectiveness of Tadalafil in Asian Men When Taken as Needed for Getting and Keeping an Erection

Lilly logo

Lilly

Status and phase

Completed
Phase 3

Conditions

Impotence

Treatments

Drug: tadalafil
Drug: placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT00547573
H6D-MC-LVDY
5874

Details and patient eligibility

About

Study to determine if tadalafil works better than placebo for Asian men having trouble getting or keeping an erection.

Enrollment

367 patients

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • History of erection problems
  • Anticipate a monogamous female sexual relationship
  • Abstain from other erection treatments at least 4 weeks before first dose and throughout the study
  • Must be able to make required sexual intercourse attempts

Exclusion criteria

  • Other primary sexual disorders
  • History of radical prostatectomy or other pelvic surgery that affected being able to have an erection
  • History of penile implant or clinically significant penile deformity
  • Nitrate use
  • Certain heart problems

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

367 participants in 3 patient groups, including a placebo group

2
Active Comparator group
Description:
10 mg tadalafil tablet
Treatment:
Drug: tadalafil
Drug: tadalafil
3
Active Comparator group
Description:
20 mg tadalafil tablet
Treatment:
Drug: tadalafil
Drug: tadalafil
1
Placebo Comparator group
Description:
placebo tablet
Treatment:
Drug: placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems